@article{Kim_S-2024_184347,
title = {Efficacy and safety of acupuncture treatment for fatigue after COVID-19 infection: study protocol for a pilot randomized sham-controlled trial},
author = {Kim, S. and Lee, J. and Kim, T. and Kim, T. and Kwon, S. and Kang, J.},
month = {nov},
year = {2024},
abstract = {Background: As the coronavirus disease 2019 (COVID-19) pandemic has spread globally, its sequelae, called Long COVID, have persisted, troubling patients worldwide. Although fatigue is known to be the most frequent among Long COVID symptoms, its mechanism and treatment have not been clearly demonstrated. In 2022, we conducted a preliminary prospective case series and found that acupuncture and moxibustion were feasible interventions for fatigue. This study is a pilot patient-assessor-blinded randomized sham-controlled trial to evaluate the efficacy and safety of acupuncture treatment for patients with fatigue that has persisted for at least 4 weeks after recovery from COVID-19.},
volume = {14},
journal = {Frontiers in Neurology},
publisher = {Frontiers Media},
url = {https://doi.org/10.3389/fneur.2023.1302793},
}
